SUMMARY
INTRODUCTION
Eosinophils play an important role in allergic disorders such as asthma, atopic dermatitis and allergic gastrointestinal diseases as well as in the elimination of parasitic infections and as part of the immune response to some cancers (10). Eosinophils release a wide variety of mediators, of which the granular proteins eosinophil peroxidase (EPO), major basic protein (MBP) and eosinophil-derived neurotoxin (EDN) appear to play a pivotal role in these conditions (3) .
In the lungs, stimulation of parasympathetic nerves in the vagus leads to bronchoconstriction via acetylcholine binding to M 3 muscarinic receptors on the airway smooth muscle (24) . Control over the release of acetylcholine is mediated by neuronal muscarinic M 2 receptors in an autocrine manner (9) . In antigen-sensitised guinea pigs after antigen challenge as well as in some asthmatic patients, there is loss of function of pulmonary neuronal M 2 muscarinic receptors which leads to increased vagally mediated bronchoconstriction (8) , (4) . In vitro ligand binding studies have shown that eosinophil major basic protein and eosinophil peroxidase are antagonists at M 2 muscarinic receptors (15) . Previously, we have demonstrated that in vivo there is a specific localisation of eosinophils and extracellular MBP to airway cholinergic nerves (5), (2) . Furthermore, inhibiting eosinophil MBP preserves M 2 receptor function in antigen-challenged guinea pigs (6) . Thus, these data suggest that eosinophils localise to cholinergic nerves and release MBP, which in turn is associated with enhanced acetylcholine release from the nerves.
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Since eosinophil granular proteins do not disperse following their release and therefore act primarily in the vicinity of the eosinophil, it is likely that the signal to degranulate is similarly localised. Previous studies have shown that the release of eosinophil granular proteins is enhanced by adhesion through specific adhesion molecules (21) . We have shown that primary cultures of airway parasympathetic cholinergic nerves and the human cholinergic neural cell line IMR32 express the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), to which eosinophils adhere (27) . In this study we investigated the hypothesis that this adhesion of eosinophils to nerves leads to eosinophil degranulation and thus leads to increased acetylcholine release from the nerves.
MATERIALS AND METHODS

Materials
Dulbecco's modified Eagles' medium (DMEM), Trowell's T8 medium and foetal calf serum (FCS) were purchased from Gibco BRL Life Technologies (Paisley, UK) and tissue culture plasticware was from Helena Biosciences (Sunderland, UK). The IMR32 cell line was obtained from ECACC (Salisbury, UK 
Eosinophil isolation
Eosinophils were prepared from the blood of healthy human volunteers by a negative immunomagnetic selection technique. After phlebotomy, 15 ml blood were added to 25 ml phosphate buffered saline (PBS) containing 100 U heparin and then layered onto a 1.090 g/ml Percoll solution. Following centrifugation at 400 g for 20 min, the upper layer and mononuclear cells were discarded and the pellet containing granulocytes and red blood cells was exposed to hypotonic lysis by treatment with 18 ml H 2 O for 30 sec followed by the addition of 2 ml PIPES buffered salt solution (250 mM PIPES, 1.1 M NaCl, 50 mM KCl, 420 mM NaOH; pH 7.47) to restore tonicity. After centrifugation at 400 g for 6 min, the pellets were pooled and resuspended in a one tenth dilution of the above PIPES buffered salt solution containing 55.5 mM glucose and 3% (w/v) human serum albumin (HSA), washed by centrifugation and the hypotonic lysis procedure repeated. The remaining granulocytes were then resuspended in MACS buffer (PBS plus 2 mM ethylenediaminetetraacetic acid (EDTA) and 0.5% bovine serum albumin (BSA)) with 1 µl CD16 immunomagnetic beads/10 6 cells and incubated for 30 min at 4°C. The cells were then washed, resuspended in MACS buffer and passed through a magnetic separation column (Miltenyi Biotech, Bisley, UK). The immunomagnetically labelled CD16-positive neutrophils were retained in the column and the eluted cells were collected and centrifuged.
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The pellet was resuspended in differentiation medium (DMEM with 2% FCS, 2 mM sodium butyrate, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 µg/ml gentamicin).
Purity of eosinophils in the suspension was >98% as determined by DiffQuick staining and the viability greater than 95 % by Trypan Blue staining.
IMR32 nerve cell culture
The IMR32 cell line was maintained at 37°C in an atmosphere of 5% CO 2 in proliferation medium consisting of DMEM with 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 µg/ml gentamicin. Upon reaching confluence, cells were plated at a density of 2x10 4 /well onto 24-well tissue culture plates and grown in proliferation medium. After 24 h this medium was removed and neurite outgrowth and a cholinergic phenotype induced by the addition of differentiation medium. Cells were typically used after a further 6-8 days of differentiation in culture.
Measurement of eosinophil peroxidase (EPO)
The release of EPO was measured as previously described (19) with some modifications.
The incubation medium of IMR32 cells, differentiated as above, was replaced with differentiation medium containing 5x10 3 freshly isolated eosinophils/well. Eosinophils were also cultured alone (5x10 
Eosinophil membrane preparations
Immediately after isolation, eosinophils were resuspended in H 2 O, incubated for 15 min on ice and then centrifuged at 1500 g for 6 min. This process was repeated twice more and then the resulting lysed cell membranes were resuspended in culture medium before addition to IMR32 cells of an amount equivalent to 5x10 3 whole eosinophils.
Measurement of acetylcholine release from IMR32 cells
Differentiated IMR32 nerve cells were radiolabelled with methyl- 
Data analysis
Data represent the mean ± SEM of at least three independent experiments. Statistical significance was estimated using one-way analysis of variance (ANOVA) with Dunnett's Post Hoc correction.
RESULTS
Eosinophil degranulation in the presence of IMR32 nerve cells
Eosinophils cultured alone on tissue culture plates released detectable levels of EPO at 2 h but there was an almost ten-fold increase in EPO release when eosinophils were cultured in the presence of IMR32 nerve cells for a similar time ( Figure 
Eosinophil-induced generation of reactive oxygen species (ROS) in IMR32 cells
To determine whether active cellular pathways within IMR32 nerve cells or simply adhesion to the nerves was required for producing an increase in eosinophil degranulation, reader. There was a steady increase in ROS produced by nerves in contact with eosinophils over a 6 h time period, reaching a plateau at 24 h (Fig 3B) . When compared with a standard curve constructed with hydrogen peroxide, the fluorescence indicated an approximate rate of production of 3 nmol ROS/ h/ 100000 cells. These increases were not due to ROS in eosinophils, since there was no significant increase in fluorescence when the eosinophils were loaded with DHR ( Figure 3B ).
When eosinophils were pretreated with mAb against CD18 (2 pg/ml) the production of ROS was reduced by 88 ± 4% at 2 h and 79 ± 10% at 24 h (p<0.001). Similarly, anti-ICAM-1 mAb inhibited ROS generation at 2 h and 24 h ( Figure 4A and 4B). Isotype matched controls produced no significant reduction in ROS production (data not shown).
Incubation with ZD7349 had no significant effect on the production of ROS at 2 h but significantly reduced the levels at 24 h ( Figure 4A and 4B). Eosinophils separated from the nerves by inserts failed to induce neuronal ROS production. IMR32 cells were pretreated for 30 min with NADPH oxidase inhibitors, either apocynin (5 mM) or diphenyleneiodonium chloride (DPI; 1 µM). Apocynin reduced the eosinophil-mediated ROS production by 83 ± 6% at 2 h and 33 ± 16% after 24 h of co-culture, while DPI completely blocked ROS production at both time points ( Figure 4C and 4D) . In contrast, the NOS inhibitor, L-NMMA (1 mM), significantly reduced the levels of ROS after 24 h but not after 2 h of co-culture.
To determine that the NADPH oxidase was localised to the IMR32 nerve cells we examined the expression of the p47 phox subunit by immunocytochemistry. Minimal background staining was observed when the nerves were treated with either the primary antibody, goat anti-human p47 phox (N-19) polyclonal antibody alone ( Figure 5A ), the secondary antibody, rabbit anti-goat HRP conjugate alone ( Figure 5B ), or the isotype matched control goat IgG in combination with secondary antibody ( Figure 5C ). An intense blue-gray staining was observed when the cells were exposed to both primary and secondary antibody ( Figure 5D ) indicating the presence of the p47 phox subunit of NADPH oxidase in IMR32 cells.
Eosinophil degranulation induced by neuronal ROS
Eosinophils cultured with IMR32 cells treated with DPI released 65 ± 26% (p<0.05) and 49 ± 2% (p<0.01) less EPO than eosinophils cultured in the presence of control nerves at 2 h and 24 h respectively ( Figure 6A and 6B). The specific NADPH oxidase inhibitor, apocynin, reduced degranulation to a similar extent but the specific NOS inhibitor; L-NMMA had no effect on degranulation ( Figure 6A and 6B) suggesting that the NADPH oxidase enzyme and its reaction product superoxide are important mediators of eosinophil degranulation. Complete inhibition of ROS in nerves did not prevent all nerve-induced eosinophil degranulation suggesting that there were other neural factors responsible.
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To determine if the ROS (or other neural factors) caused degranulation of only those eosinophils directly in contact with nerves, we separated eosinophils from nerves in a transwell insert and then generated ROS by incubation of nerves with lysed eosinophil membranes. Under these conditions, there was an increase in neuronal ROS comparable to the addition of whole eosinophils which was also sensitive to anti-CD18 mAb (data not shown). Furthermore, there was a significant release of EPO from non-adhered eosinophils at 2 h and 24 h and this degranulation was completely blocked by DPI ( Figure 6C and 6D) indicating that ROS from nerves could mediate degranulation of eosinophils not directly in contact with nerves.
Effect of eosinophils on stimulated acetylcholine release
Eosinophils can elicit M 2 receptor dysfunction in vivo (5) 
DISCUSSION
The results of this study show that contact between eosinophils and cholinergic nerves leads to eosinophil degranulation and an increase in acetylcholine release from the nerves.
The nerve-induced eosinophil degranulation was dependent on the interactions of the eosinophil integrins, CD11/18 and VLA-4 and the neuronal adhesion molecules ICAM-1 and VCAM-1. In particular, adhesion to IMR32 cells resulted in the production of neural reactive oxygen species, which, along with other factors released from the nerves, induced the eosinophil degranulation. Similarly, the increased acetylcholine release was dependent on eosinophil adhesion to the nerves.
In previous in vivo and in vitro studies we have shown that eosinophils influence cholinergic nerve function (5), (27) . In order to investigate the nature of the interaction between these two cell types we firstly investigated the effect of contact with cholinergic 
integrins (14). Studies of eosinophils in co-
culture with an epithelial cell line have indicated that adhesion is necessary for the release of eosinophil cationic protein (ECP) (28) . In that study the eosinophils were found to release approximately 15% of total ECP and in our nerve-induced degranulation studies we found a similar level of total EPO release. Furthermore, the levels of released peroxidase activity that we observed were of a similar magnitude to that induced by PAF (16) suggesting the effect to be physiologically significant. We have previously shown that Having demonstrated that adhesion leads to both degranulation and priming of eosinophils and that these are mediated by different processes, we investigated the underlying mechanisms in more detail, addressing specifically the role of adhesion molecules in generating signals in nerves. Using a fluorescent probe system that is highly sensitive to changes in cellular reactive oxidants we assessed the effects of adhesion of eosinophils to nerves on the generation of intra-neuronal ROS. After contact with eosinophils, ROS were generated in nerves within half an hour and persisted for a period in excess of twenty-four hours. This was inhibited by antibodies to either CD11/18 or ICAM-1 suggesting that these interactions were responsible for the generation of neuronal ROS and is similar to observations in neutrophil-endothelial cell interactions (31), (32) . Furthermore, the production of neuronal ROS was blocked by both DPI and apocynin, which are inhibitors of NADPH oxidase. After 24 h, the NOS inhibitor, L-NMMA, also reduced the production of ROS, suggesting that a secondary generation of peroxynitrite also occurred (20) .
The expression of NADPH oxidase was previously believed to be restricted to nonneuronal cells. However, recent studies have indicated that this enzyme is present in sympathetic neurones (29) . We have now also shown by immunocytochemistry that IMR32 cells express the p47 phox subunit of NADPH oxidase. The NADPH oxidase complex has been extensively studied in inflammatory cells including eosinophils and neutrophils, where it functions to produce high levels of ROS. In our experiments however, we could not detect the production of ROS within eosinophils but rather the ROS were derived from the nerves alone. The levels of ROS were comparable to those previously described by activation of NADPH oxidase in inflammatory cells (17). It was clearly important to identify if the ROS generation within the cholinergic IMR32 cells was responsible for the nerve-induced eosinophil degranulation. Eosinophils were therefore cocultured with IMR32 cells in the presence of inhibitors of NADPH oxidase and the effect of these on degranulation was assessed. When eosinophils were added to IMR32 cells that had been pre-treated with DPI or apocynin but not L-NMMA and therefore generated no ROS, there was a significant but incomplete inhibition of eosinophil degranulation. These data suggest that eosinophil adhesion to IMR32 cells leads to degranulation only partly through the generation of ROS. The mechanism of ROS-induced degranulation is not established. There may be a direct effect of ROS released from the nerves or an indirect mechanism, for example, by altering cell adhesion or responses to chemotactic factors which nerves are known to secrete or affecting the release of eosinophil autocrine mediators (22), (25) , (26) .
The fact that inhibition of the neuronal ROS did not completely inhibit the nerve-induced degranulation suggests that eosinophil adhesion might lead to another neural factor being released. Experiments were performed using eosinophil membranes as a means of crosslinking ICAM-1 with CD11/18 but independent of local EPO release, since it was necessary to determine whether degranulation could occur in eosinophils not in contact with nerves. When eosinophils were separated from nerves stimulated with eosinophil membranes there was some degranulation but less than which occurred when whole eosinophils were in contact with nerves. This reduction in degranulation may have a number of explanations. Either a nerve-released factor did not pass through the trans-well membrane or eosinophils needed to be in contact with nerves for them to respond to this factor. Alternatively, eosinophil-nerve contact leads to release of an autocrine mediator from eosinophil that contributes to degranulation. For instance, other studies have shown that platelet-activating factor (PAF) generated by eosinophils that have adhered via ß 2 integrins can directly induce eosinophil degranulation (1). Our preliminary experiments (results not shown) indicate that the factor in our preparations was not PAF, since the PAF antagonist CV6209 did not affect eosinophil degranulation. Further studies will be required to identify the nature of the other neural factors that induce eosinophil activation and degranulation.
Having demonstrated that eosinophil degranulation occurred following contact with cholinergic nerves we assessed the effects of this process on stimulated acetylcholine release. In experiments in which eosinophils were allowed to adhere to IMR32 cells, both spontaneous and stimulated acetylcholine release was significantly enhanced compared to baseline levels. This increase in acetylcholine release was significantly inhibited by pretreatment with an antibody to CD11/18. Thus, eosinophil adhesion to IMR32 cells was associated with enhanced cholinergic nerve activity. This is consistent with the eosinophils influencing activity at M 2 receptors.
In summary, these studies indicate that contact between eosinophils and cholinergic nerves leads to eosinophil degranulation due to neural factors including reactive oxygen species. Eosinophil contact with nerves also leads to an increase in acetylcholine release from the nerves. Eosinophil degranulation in association with nerves and the subsequent alteration in nerve function may occur in a number of disease states. For example, degranulation of eosinophils close to airway nerves is seen in animal models of antigeninduced hyperreactivity and in gastrointestinal diseases (13) . In addition, eosinophil 21
proteins are implicated in a number of neurological conditions including Gordon's syndrome, muscle rigidity and ataxia due to eosinophil derived neurotoxin (7) and also as part of the immune response of some brain cancers (23) , (30), (33) . Hence the mechanisms of nerve-induced eosinophil degranulation described in this report may be relevant to a number of neuro-inflammatory conditions. Eosinophil number (x10 3 )
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